
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
- Volume 4
- Issue 4 Suppl
Secondary Prevention
Author(s)John S. Banas, Jr., MD
Advertisement
Articles in this issue
about 28 years ago
Participating Facultyabout 28 years ago
Coronary Heart Disease in the United Statesabout 28 years ago
Mechanisms of Acute Coronary Eventsabout 28 years ago
Primary Preventionabout 28 years ago
Pravastatin Event Reduction Analysisabout 28 years ago
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?about 28 years ago
Methods and Mindsets in Pharmacoeconomicsabout 28 years ago
Issues and Controversies in Pharmacoeconomicsabout 28 years ago
Pharmacoeconomics Perspectives: Payers, Providers, and PatientsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
3
Bridging Science and Reality in Diabetes Care
4
Nutrition in Pregnancy May Shape Metabolic Health After Delivery
5




